YOU'RE INVITED
YOU'RE INVITED
CELL AND GENE THERAPY PARTNERSHIP DISCUSSION
CELL AND GENE THERAPY PARTNERSHIP DISCUSSION
TOGETHER FOR SCIENCE
CATE DYER
CEO & FOUNDER
TOGETHER FOR SCIENCE
Learn About Cell & Gene Therapies with StemExpress
Presented by CEO & Founder, Cate Dyer & Chief Medical Officer, Dr. Gregory Graves
We want to personally invite you to our company headquarters in Folsom, California for a discussion and facility tour on the process to provide lifechanging cell and gene therapies to patients throughout Northern California.
Through our own dedicated centers focused on patient cell collection, to our state-of-the-art laboratory featuring the best cell isolation, expansion and modification equipment available globally, we have prepared an event designed to provide you with unmatched insight and visibility to the tools and partnership required for successful implementation of cell and gene therapies to support your patients.
We look forward to hosting this educational event on the vast potential of cell & gene based therapies and how through partnership with StemExpress, your institution can scale the cutting edge needs of your patients by offering the best treatments available globally, right in our community.
What to Expect at the Event
ADDITIONAL CELL & GENE THERAPY RESOURCES
Check out these resources before you attend the event
CliniMACS Prodigy® - Automated cell processing in a closed system
CliniMACS Prodigy® - Automated cell processing in a closed system
The CliniMACS Prodigy®, manufactured by Miltenyi Biotec, is a closed and automated platform that streamlines GMP-compliant cell manufacturing.
The system provides a closed loop process for CAR T cell manufacturing for cancer patient therapies.
We will provide a demo of the Miltenyi Biotec equipment at the event.
California Based Cancer Center uses CAR T Cell Therapies
The City of Hope, a NCI-designated Comprehensive Cancer Center, has been at the forefront of CAR T cell therapy. Their website, linked below, offers great videos on the approach of using CAR T cell therapy to defeat cancer.
UK BIOSCIENCES COMPANY PARTNERS WITH STEMEXPRESS TO CURE CANCER
LIfT Biosciences is a biotech bringing to market a first-in-class 'off-the-shelf' innate cell therapy called Neutrophil based Leukocyte Infusion Therapy (N-LIfT). N-LIfT is the world's first neutrophil-based cancer therapeutic product that has the game-changing potential to destroy all solid tumours irrespective of mutation or strain. N-LIfT uses a special type of N1a neutrophil with special cancer killing and immune recruitment capabilities, whilst additionally maintaining minimal damage to healthy cells.
Use the link provided below to learn more about the vision of LifT and its courageous mission to eradicate some of the world's most challenging tumors.
LEARN MORE ABOUT STEMEXPRESS
We are the leading global biospecimen provider of human primary cells, stem cells, bone marrow, cord blood, peripheral blood, and disease-state products
Advancing Medical Breakthroughs
Advancing Medical Breakthroughs
Founded in 2010, we know how important biospecimens are to medical research and how frustrating it can be waiting for samples.
StemExpress is dedicated to accelerating research projects at life-changing speed to aid in the development of new treatments and even cures for patients worldwide.